My name is Dale Yuzuki, and recently joined a firm called SeraCare based in Milford, MA that manufactures products used in the in-vitro diagnostic industry. SeraCare manufactures infectious disease controls, provides disease-state materials and serum and plasma-based products for companies worldwide.
As a Director of Market Development, I’ll be combining both product development and marketing roles to launch new next-generation sequencing products into the translational clinical diagnostics area, which is under increasing scrutiny and regulation from federal agencies. As NGS receives greater importance in clinical diagnostics, the need for effective controls and uniform metrics is an important one.
As far as my background – in brief: I’ve taught middle-school and high-school level biology and chemistry (M.Ed. from UCLA), worked as a cancer and immunology researcher from the Veteran’s Administration in San Francisco and the John Wayne Institute in Santa Monica (M.A. from SFSU), taught English overseas in Beijing China, answered 1-800-DNA-PREP calls for QIAGEN, supported product development and tactical marketing efforts at both QIAGEN and Illumina, sold whole-genome genotyping, expression, and next-generation sequencing instruments to the NIH and Hopkins, and for several years was a field-based marketing professional for the Americas region for the Life Science Solutions Group for Thermo Fisher Scientific. You can find many of the interviews I did for Thermo Fisher Scientific here on YouTube, and a link to the Behind the Bench blog posts can be accessed here.